BioCentury
ARTICLE | Clinical News

Bimekizumab: Phase Ib data

July 25, 2016 7:00 AM UTC

Top-line data from a double-blind, European Phase Ib trial in 52 patients with psoriatic arthritis who had inadequate responses to >=1 DMARD and/or 1 biologic showed that pooled data from the top 3 do...